https://www.selleckchem.com/products/MK-1775.html
LRTs for LMs represent a valuable option for the treatment of metastatic TC in case of isolated hepatic progression or for symptoms relief, also after thestart of TKI treatment as part of a multimodal approach. The best disease control is obtained when hepatic metastatic burden is limited. These procedures are generally well tolerated; however, a cautious multidisciplinary selection of the candidates is mandatory. LRTs for LMs represent a valuable option for the treatment of metastatic TC in case of isolated hepatic progression or for s